Ocular Therapeutix’ investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.